Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Costantinos Dimitriou"'
Autor:
Andriana Christodoulou, Panagiota-Efstathia Nikolaou, Lydia Symeonidi, Konstantinos Katogiannis, Louisa Pechlivani, Theodora Nikou, Aimilia Varela, Christina Chania, Stelios Zerikiotis, Panagiotis Efentakis, Dimitris Vlachodimitropoulos, Nikolaos Katsoulas, Anna Agapaki, Costantinos Dimitriou, Maria Tsoumani, Nikolaos Kostomitsopoulos, Constantinos H. Davos, Alexios Leandros Skaltsounis, Alexandros Tselepis, Maria Halabalaki, Ioulia Tseti, Efstathios K. Iliodromitis, Ignatios Ikonomidis, Ioanna Andreadou
Publikováno v:
Redox Biology, Vol 76, Iss , Pp 103311- (2024)
Clinical studies have previously established the role of olive products in cardiovascular disease (CVD) prevention, whilst the identification of the responsible constituents for the beneficial effects is still pending. We sought to assess and compare
Externí odkaz:
https://doaj.org/article/4f4fdd05cf5c41da9bd3e91974f80717
Autor:
Panagiotis Efentakis, Sofia Lamprou, Manousos Makridakis, Ioanna Barla, Panagiota-Efstathia Nikolaou, Andriana Christodoulou, Costantinos Dimitriou, Nikolaos Kostomitsopoulos, Ioannis Ntanasis-Stathopoulos, Irene Theochari, Maria Gavriatopoulou, Harikleia Gakiopoulou, Androniki Tasouli, Antonia Vlahou, Evangelos Gikas, Nikolaos Thomaidis, Meletios-Athanasios Dimopoulos, Evangelos Terpos, Ioanna Andreadou
Publikováno v:
HemaSphere, Vol 6, Iss 11, p e791 (2022)
Carfilzomib is an irreversible proteasome inhibitor indicated for relapsed/refractory multiple myeloma. Carfilzomib toxicity includes renal adverse effects (RAEs) of obscure pathobiology. Therefore, we investigated the mechanisms of nephrotoxicity de
Externí odkaz:
https://doaj.org/article/fc5d420a1abb40f487384cc2e97d1092